Wermeling D P, Foster T S, Farrington E A, Witt W O, Gallion H H, Donaldson E, van Nagell J R, Outman W R, McPherson D P
Drug Product Evaluation Unit, College of Pharmacy, University of Kentucky Medical Center, Lexington.
Acute Care. 1988;12 Suppl 1:31-9.
Patient-controlled analgesia (PCA) has been studied extensively for the treatment of postoperative pain using narcotic analgesics. Butorphanol, a nonnarcotic injectable analgesic, has not previously been investigated using this drug delivery mechanism. Twenty-five patients undergoing general abdominal surgery and general anesthesia used a PCA device with butorphanol as the analgesic agent. Most patients (84%) were able to obtain excellent postoperative pain relief. The role of butorphanol in the management of postoperative pain should be expanded to include patient-controlled drug delivery.